Association of antibiotics with the outcomes in COVID-19 pneumonia patients with elevated PCT levels.

Lekhya RaaviShahin IshaSadhana JonnaEmily C CraverHrishikesh NatarajaAnna JenkinsAbby J HansonArvind Bala VenkataramanPrasanth BalasubramanianAysun TekinVikas BansalSean M CaplesSyed Anjum KhanNitesh K JainAbigail T LaNouRahul KashyapRodrigo Cartin-CebaBhavesh M PatelRicardo Diaz MilianCarla P VenegasAnna B ShapiroAnirban BhattacharyyaSanjay ChaudharySean P KileyYoung M ErbenQuintin J QuinonesNeal M PatelPramod K GuruPablo Moreno FrancoArchana RoyDevang K Sanghavi

Published in: Respiratory medicine (2024)

Our study shows a substantial number of COVID-19 pneumonia patients received antibiotics despite a low incidence of bacterial infections. Therefore, antibiotics use in COVID pneumonia patients with PCT <0.5 in the absence of clinical evidence of bacterial infection has no beneficial effect.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
ejection fraction
respiratory syndrome coronavirus
respiratory failure
community acquired pneumonia
type diabetes
metabolic syndrome
intensive care unit
skeletal muscle
patient reported outcomes
weight loss